Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6267343, 8 pages
http://dx.doi.org/10.1155/2016/6267343
Research Article

Identification and Prioritization of the Economic Impacts of Vaccines

1CAPHRI, School of Public Health and Primary Care, Department of Health Services Research, Maastricht University, Maastricht, Netherlands
2Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland

Received 3 June 2016; Accepted 24 October 2016

Academic Editor: Kumud K. Kafle

Copyright © 2016 Ingeborg M. van der Putten et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNICEF, “Commiting to child survival: a promise reviewed,” Progress Report 2013, UNICEF, New York, NY, USA, 2013. View at Google Scholar
  2. World Health Organization, Global Health Observatory: Under Five Mortality, 2015, http://www.who.int/gho/child_health/mortality/mortality_under_five_text/en/index.html.
  3. World Health Organization, Immunization coverage, 2015, http://www.who.int/mediacentre/factsheets/fs378/en/.
  4. WHO, UNICEF, and World Bank, State of the World's Vaccines and Immunization, WHO, Geneva, Switzerland, 2009.
  5. WHO, Principles and Considerations for Adding a Vaccine to a National Immunization Programme: From Decision to Implementation and Monitoring, WHO, Geneva, Switzerland, 2014.
  6. M. Chan, “Investing in health: progress but hard choices remain,” The Lancet, vol. 382, no. 9908, pp. e34–e35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. E. D. Burchett, S. Mounier-Jack, U. K. Griffiths et al., “New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries,” Health Policy and Planning, vol. 27, supplement 2, pp. ii5–ii16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. E. D. Burchett, S. Mounier-Jack, U. K. Griffiths, and A. J. Mills, “National decision-making on adopting new vaccines: a systematic review,” Health Policy and Planning, vol. 27, supplement 2, pp. ii62–ii76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Mansoor, S. Shin, and C. Maher, Assessing New Vaccines for National Immunization Programmes. A Framework to Assist Decision Makers, World Health Organization Regional Office for the Western Pacific Manila, Manila, Pa, USA, 2000.
  10. H. Engström, P. T. Khin, A. Coll-Seck et al., “Reinvesting in health post-2015,” The Lancet, vol. 382, no. 9908, pp. 1861–1864, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Jit and R. Hutubessy, “Methodological challenges to economic evaluations of vaccines: is a common approach still possible?” Applied Health Economics and Health Policy, vol. 14, no. 3, pp. 245–252, 2016. View at Publisher · View at Google Scholar
  12. T. Barnighausen, S. Berkley, Z. A. Bhutta et al., “Reassessing the value of vaccines,” The Lancet Global Health, vol. 2, no. 5, pp. e251–e252, 2014. View at Publisher · View at Google Scholar
  13. R. Deogaonkar, R. Hutubessy, I. Van Der Putten, S. Evers, and M. Jit, “Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries,” BMC Public Health, vol. 12, no. 1, article 878, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ozawa, A. Mirelman, M. L. Stack, D. G. Walker, and O. S. Levine, “Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review,” Vaccine, vol. 31, no. 1, pp. 96–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Jit, R. Hutubessy, M. E. Png et al., “The broader economic impact of vaccination: reviewing and appraising the strength of evidence,” BMC Medicine, vol. 13, no. 1, article 209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Schwartz and A. Mahmoud, “When not all that counts can be counted: economic evaluations and the value of vaccination,” Health Affairs, vol. 35, no. 2, pp. 208–211, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. I. M. van der Putten, S. M. A. A. Evers, R. Deogaonkar, M. Jit, and R. C. W. Hutubessy, “Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study,” BMC Public Health, vol. 15, no. 1, article 356, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Bärnighausen, D. E. Bloom, E. T. Cafiero-Fonseca, and J. C. O'Brien, “Valuing vaccination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 34, pp. 12313–12319, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. C. Mühlbacher, A. Kaczynski, P. Zweifel, and F. R. Johnson, “Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview,” Health Economics Review, vol. 6, no. 1, pp. 1–14, 2015. View at Google Scholar
  20. T. N. Flynn, J. J. Louviere, T. J. Peters, and J. Coast, “Best-worst scaling: what it can do for health care research and how to do it,” Journal of Health Economics, vol. 26, no. 1, pp. 171–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Qualtrics LLC, Qualtrics, 2016, https://www.qualtrics.com/.
  22. R. Johnson, Understanding HB: An Intuitive Approach. Sawtooth Software 2000, 2010.
  23. B. Orme, SSI Web v8.3: Woftware for Web Interviewing and Conjoint Analysis, Sawtooth Software, Orem, Utah, USA, 2014.
  24. A. Field, Discovering Statistics Using IBM SPSS Statistics, Sage, 2013.
  25. N. M. Ferguson, I. Rodriguez-Barraquer, I. Dorigatti, L. Mier-y-Teran-Romero, D. J. Laydon, and D. A. Cummings, “Benefits and risks of the Sanofi-Pasteur dengue vaccine: modeling optimal deployment,” Science, vol. 353, no. 6303, pp. 1033–1036, 2016. View at Publisher · View at Google Scholar
  26. N. de Francisco Shapovalova, “A systematic review of the social and economic burden of influenza in low- and middle-income countries,” Vaccine, vol. 33, no. 48, pp. 6537–6544, 2015. View at Publisher · View at Google Scholar
  27. Y. Tozan, “Current issues in the economics of vaccination against dengue,” Expert Review of Vaccines, vol. 15, no. 4, pp. 519–528, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Flasche, Jit M,, I. Rodriguez-Barraquer et al., Comparative Modelling of Dengue Vaccine Public Health Impact (CMDVI), World Health Organization, Geneva, Switzerland, 2016.